Big Pharma Leverages Early-Stage Risk with Innovative Options

Black Hawk’s subsidiary, BH Merger Sub, will merge with Vesicor as part of the agreement.

This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.

The investment agreement will support the company’s ongoing clinical trials for its treatment for the rare genetic condition, spinocerebellar ataxia.

Learn Morewww.bio-rad.com/fluvaccine

Through the collaboration, Pharmaron will validate and promote the application of CN Bio’s PhysioMimix technology with plans to integrate OOC technologies into its R&D platform.

AnalytiChem has launched the Redipor line of ready-to-use culture media, which brings three well-known brands under one global brand.